ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,132
Screening encounters
4,910
Diagnostic referrals
935
Outstanding pathways
324

Screening pathway

  1. Screening4,910Encounters
  2. Positive finding1,695Documented findings
  3. Referral935Diagnostic referrals
  4. Follow-up1,117Diagnostic visits
  5. Outcome611Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1663 · EXP-1663Synthetic · Site A

Full participant history through 2027-01-11, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

No matching referral was available at this observation date.

Screened participants

4132 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1611 · Expanded synthetic participant 1611Site C — Rural Outreach Programme
EXP-1612 · Expanded synthetic participant 1612Site D — Community Engagement Programme
EXP-1613 · Expanded synthetic participant 1613Site E — Resource-Constrained Navigation Programme
EXP-1615 · Expanded synthetic participant 1615Site E — Resource-Constrained Navigation Programme
EXP-1617 · Expanded synthetic participant 1617Site B — Peri-Urban Access Programme
EXP-1618 · Expanded synthetic participant 1618Site D — Community Engagement Programme
EXP-1619 · Expanded synthetic participant 1619Site C — Rural Outreach Programme
EXP-1620 · Expanded synthetic participant 1620Site D — Community Engagement Programme
EXP-1621 · Expanded synthetic participant 1621Site A — Urban Referral Hub
EXP-1622 · Expanded synthetic participant 1622Site A — Urban Referral Hub
EXP-1623 · Expanded synthetic participant 1623Site C — Rural Outreach Programme
EXP-1624 · Expanded synthetic participant 1624Site C — Rural Outreach Programme
EXP-1625 · Expanded synthetic participant 1625Site C — Rural Outreach Programme
EXP-1626 · Expanded synthetic participant 1626Site A — Urban Referral Hub
EXP-1627 · Expanded synthetic participant 1627Site B — Peri-Urban Access Programme
EXP-1628 · Expanded synthetic participant 1628Site A — Urban Referral Hub
EXP-1630 · Expanded synthetic participant 1630Site C — Rural Outreach Programme
EXP-1631 · Expanded synthetic participant 1631Site A — Urban Referral Hub
EXP-1632 · Expanded synthetic participant 1632Site C — Rural Outreach Programme
EXP-1633 · Expanded synthetic participant 1633Site D — Community Engagement Programme
EXP-1634 · Expanded synthetic participant 1634Site D — Community Engagement Programme
EXP-1635 · Expanded synthetic participant 1635Site D — Community Engagement Programme
EXP-1636 · Expanded synthetic participant 1636Site B — Peri-Urban Access Programme
EXP-1637 · Expanded synthetic participant 1637Site B — Peri-Urban Access Programme
EXP-1639 · Expanded synthetic participant 1639Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1866
HPV DNA
2356
Cytology
688

Navigation activity

Barrier documented
836
Contact attempt
1363
Navigation intervention
367
Diagnostic booking
1160
Diagnostic visit
1117

Documented barriers

Contact difficulty
266
Transport difficulty
277
Appointment coordination
293

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.